The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer
Clinical trial NCT02653755 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02653755
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-15
- Primary completion
- 2030-05-15
- Enrollment
- 671
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.